How much funding has Akouos raised?

Akouos has raised $162.5M in total funding, most recently a Series B round.

Who are Akouos's investors?

Akouos's investors include 5AM Ventures, New Enterprise Associates, Eli Lilly, Pivotal bioVenture Partners.

Where is Akouos headquartered?

Akouos is headquartered in Boston, Massachusetts, United States.

What industry is Akouos in?

Akouos operates in Biotech, Therapeutics, Genomics.

Akouos

Acquired

Healthy hearing available to all

Boston, United States · Founded 2016 · $162.5M raised

Biotech

Therapeutics

Genomics

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: akouos.com
Total Funding: $162.5M
Last Round: $105.0M Series BMar 2020
Rounds: 3

About

Akouos is a precision genetic medicine company developing gene therapies to restore, improve, and preserve high-acuity physiologic hearing for people with disabling hearing loss. Focused on inner ear delivery and AAV gene therapy platforms, it was acquired by Eli Lilly. Targets genetic forms of hearing loss affecting 466 million worldwide.

Summary

Akouos is a Biotech company based in Boston, United States, founded in 2016. It has raised $162.5M in total across 3 rounds, most recently a $105.0M Series B round in Mar 2020. Investors include 5AM Ventures, New Enterprise Associates and Eli Lilly.

LinkedIn X (Twitter)